Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Cyclopentanohydrophenanthrene ring system doai
Patent
1993-06-23
1995-12-26
Rizzo, Nicholas
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Cyclopentanohydrophenanthrene ring system doai
540102, 540104, C07J 1900, C07D30758, A61K 31585
Patent
active
054788170
ABSTRACT:
Digitoxigenin and dihydrodigitoxigenin 3.beta.-derivatives, a process for their preparation and pharmaceutical compositions containing same for the treatment of cardiovascular disorders such as heart failure and hypertension are disclosed.
REFERENCES:
patent: 4259240 (1981-03-01), Werner et al.
Stoll et al, Helv. Chim. Acta vol. 17 pp. 592-613 (1934).
Jorgensen, Biochimica and Biophysica Acta vol. 356 pp. 36-52 (1974).
Erdmann et al, Arzneim Forsh vol. 34 pp. 1314-1318 (1984).
Mall et al, Biochem. Pharm. vol. 33 pp. 47-52 (1984).
Bobbio J. Org. Chem vol. 26 pp. 3023-3024 (1961).
Abramson et al, J. Pharm. Sciences vol. 66 pp. 602-603 (1977).
Weiss et al, Helvetica Chim Acta vol. 55 pp. 2452-2460 (1972).
Roder et al, J. Arch. Pharm vol. 318 pp. 837-842 (1985).
Bernardi Luigi
Ferrari Patrizia
Gobbini Mauro
Melloni Piero
Torri Marco
Rizzo Nicholas
Sigma-Tau Industrie Farmaceutiche Riunite S.p.A.
LandOfFree
Digitoxigenin and dihydrodigitoxigenin 3.beta.-derivatives and p does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Digitoxigenin and dihydrodigitoxigenin 3.beta.-derivatives and p, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Digitoxigenin and dihydrodigitoxigenin 3.beta.-derivatives and p will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1369283